Health Care | Pharmaceuticals and Biotechnology

TALS 5 Dimension Analysis

Analysis Instruction of TALS

Due to insufficient company valuation data, it is not possible to provide a rating.
2. The current stock trend is bullishwith momentum accumulation in the intermediate-term.
3. The current potential for an upward price swing is lower, awaiting a swing trading score of 4 or above.
4. The institutional ownership stands at 62.17%, indicating relatively concentrated ownership. Latest quarter: 34 institutions bought, 45 institutions sold.
5. No dividend history, not ideal for dividend-oriented buy-and-hold strategy.

Due to insufficient company valuation data, it is not possible to provide a rating.
2. The current stock trend is bullishwith momentum accumulation in the intermediate-term.
3. The current potential for an upward price swing is lower, awaiting a swing trading score of 4 or above.
4. The institutional ownership stands at 62.17%, indicating relatively concentrated ownership. Latest quarter: 34 institutions bought, 45 institutions sold.
5. No dividend history, not ideal for dividend-oriented buy-and-hold strategy.